Javascript must be enabled to continue!
HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
View through CrossRef
Abstract
Autophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis. However, the underlying mechanisms remain unclear. High mobility group box protein 1 (HMGB1) is associated with both pyroptosis and autophagy. lipopolysaccharide (LPS), an important pathogenic factor involved in sepsis. Lentivirus-mediated HMGB1 shRNA was used to inhibit the expression of HMGB1. Macrophages were treated with acetylation inhibitor (AA) to suppress the translocation of HMGB1 from the nucleus to the cytosol. Autophagy and pyroptosis-related protein expressions were detected by Western blot. The levels of caspase-1 activity were detected and the rate of pyroptotic cells was detected by flow cytometry. LPS induced autophagy and pyroptosis of macrophages at different stages, and HMGB1 downregulation decreased LPS-induced autophagy and pyroptosis. Treatment with acetylation inhibitor (anacardic acid) significantly suppressed LPS-induced autophagy, an effect that was not reversed by exogenous HMGB1, suggesting that cytoplasmic HMGB1 mediates LPS-induced autophagy of macrophages. Anacardic acid or an anti-HMGB1 antibody inhibited LPS-induced pyroptosis of macrophages. HMGB1 alone induced pyroptosis of macrophages and this effect was inhibited by anti-HMGB1 antibody, suggesting that extracellular HMGB1 induces macrophage pyroptosis and mediates LPS-induced pyroptosis. In a word, HMGB1 plays different roles in mediating LPS-induced autophagy and triggering pyroptosis according to subcellular localization.
Research Square Platform LLC
Title: HMGB1 mediates lipopolysaccharide-induced macrophage autophagy and pyroptosis
Description:
Abstract
Autophagy and pyroptosis of macrophages play important protective or detrimental roles in sepsis.
However, the underlying mechanisms remain unclear.
High mobility group box protein 1 (HMGB1) is associated with both pyroptosis and autophagy.
lipopolysaccharide (LPS), an important pathogenic factor involved in sepsis.
Lentivirus-mediated HMGB1 shRNA was used to inhibit the expression of HMGB1.
Macrophages were treated with acetylation inhibitor (AA) to suppress the translocation of HMGB1 from the nucleus to the cytosol.
Autophagy and pyroptosis-related protein expressions were detected by Western blot.
The levels of caspase-1 activity were detected and the rate of pyroptotic cells was detected by flow cytometry.
LPS induced autophagy and pyroptosis of macrophages at different stages, and HMGB1 downregulation decreased LPS-induced autophagy and pyroptosis.
Treatment with acetylation inhibitor (anacardic acid) significantly suppressed LPS-induced autophagy, an effect that was not reversed by exogenous HMGB1, suggesting that cytoplasmic HMGB1 mediates LPS-induced autophagy of macrophages.
Anacardic acid or an anti-HMGB1 antibody inhibited LPS-induced pyroptosis of macrophages.
HMGB1 alone induced pyroptosis of macrophages and this effect was inhibited by anti-HMGB1 antibody, suggesting that extracellular HMGB1 induces macrophage pyroptosis and mediates LPS-induced pyroptosis.
In a word, HMGB1 plays different roles in mediating LPS-induced autophagy and triggering pyroptosis according to subcellular localization.
Related Results
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
ROLE OF HMGB1 IN DOXORUBICIN-INDUCED MYOCARDIAL APOPTOSIS AND ITS REGULATION PATHWAY
Objectives
Doxorubicin (DOX) is a widely used anti-tumour agent. The clinical application of the medication is limited by its side effect which can elicit myocard...
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Is anti-HMGB1 Antibody a Potential Characteristic Autoantibody for Sjögren's Syndrome?
Abstract
BACKGROUND: Sjögren's syndrome (SS) is a common chronic inflammatory autoimmune disease, affects about 0.33% to 0.77% population in China. The positive for antinuc...
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Significant advances have been made recently in the development of targeted therapy for lung adenocarcinoma. However, platinum-based chemotherapy remains as the cornerstone in the ...
Pan-Cancer Analyses of Pyroptosis With Functional Implications in Prognosis and Immunotherapy in Cancer
Pan-Cancer Analyses of Pyroptosis With Functional Implications in Prognosis and Immunotherapy in Cancer
Abstract
Background
Programmed cell death is an active and orderly form of cell death regulated by intracellular genes, which plays an important role in the normal occurre...
HMGB1 as a cytokine and therapeutic target
HMGB1 as a cytokine and therapeutic target
HMGB1 is an abundant nuclear and cytoplasmic protein present in mammalian cells. It is traditionally known as a DNA binding protein involved in maintenance of nucleosome structure ...
Neutrophil Extracellular Traps Facilitate Sympathoexcitation After Traumatic Brain Injury Via HMGB1/AP1 Signaling Pathway
Neutrophil Extracellular Traps Facilitate Sympathoexcitation After Traumatic Brain Injury Via HMGB1/AP1 Signaling Pathway
Abstract
Background: Traumatic brain injury (TBI) usually accompanies with sympathetic excitation, and paradoxical sympathetic hyperactivity (PSH) may be detrimental to the...
Simvastatin suppressed HMGB1-RAGE axis and atherosclerosis via mevalonate pathway
Simvastatin suppressed HMGB1-RAGE axis and atherosclerosis via mevalonate pathway
Objective
Recent studies suggested that high mobility group box 1 (HMGB1) and receptor for advanced glycation end products (RAGE) contribute to atherosclerosis, a...
HMGB1 as a Biomarker for Myeloproliferative Neoplasm Complicated with Atherosclerosis
HMGB1 as a Biomarker for Myeloproliferative Neoplasm Complicated with Atherosclerosis
Abstract
Objective
The study analyzed the correlation between levels of HMGB1 in patient's serum and biochemical indices related to atherosclerosis, clarifying the diagnos...


